1-11 of 11
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast ReplayWhen “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Kimberly Cockerham, MD
Why Staging TED Correctly Matters Even When CAS Is Low
MinuteCE®Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS
Kimberly Cockerham, MD
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Prem S. Subramanian, MD, PhD
Kimberly Cockerham, MD
Overcoming Real-World Barriers to TED Treatment
MinuteCE®Overcoming Real-World Barriers to TED Treatment
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
- advertisement
Designing Efficient Clinic Workflows for TED Therapy Access
MinuteCE®Designing Efficient Clinic Workflows for TED Therapy Access
Prem S. Subramanian, MD, PhD
Kimberly Cockerham, MD
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
MinuteCE®Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
MinuteCE®Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Andrea Lora Kossler, MD, FACS
Kimberly Cockerham, MD
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
MinuteCE®Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Prem S. Subramanian, MD, PhD
Kimberly Cockerham, MD
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
CME/CE Broadcast ReplayEmerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
- advertisement